Literature DB >> 2689622

Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components.

M D Robertson1, K M Kerr, A Seaton.   

Abstract

Spores of Aspergillus fumigatus can interfere with certain aspects of phagocytic cell function. In this study we have looked at the ability of human pulmonary macrophages to bind and kill spores of A. fumigatus which have been opsonized in untreated and heat-treated serum. For comparison, the non-pathogenic fungus Penicillium ochrochloron has been used. More than 60% of spores of both fungal species became cell-associated with the macrophages following incubation at 37 degrees C for 1 h. Spores of A. fumigatus opsonized in 5% pooled normal serum were significantly more resistant to killing by pulmonary macrophages than similarly opsonized spores of P. ochrochloron (p less than 0.02). However, serum which had been heated to 56 degrees C for 30 min prior to opsonization significantly increased (by approximately 80%) the ability of pulmonary macrophages to kill spores of A. fumigatus when compared with untreated sera (p less than 0.001). No such difference occurred with spores of P. ochrochloron. These unexpected observations fit with the known propensity of A. fumigatus to colonize the airways of patients with asthma and cystic fibrosis, conditions in which a protein-rich bronchial exudate characteristically occurs. Moreover, the presence of such a protective mechanism in a soil organism strongly suggests that complement-like substances may also play a role in protozoal phagocytosis. This is an area of research that does not appear to have been investigated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689622     DOI: 10.1080/02681218980000401

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  7 in total

1.  Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.

Authors:  K A Marr; M Koudadoust; M Black; S A Balajee
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Invasive pulmonary aspergillosis in non-immunocompromised patients.

Authors: 
Journal:  BMJ       Date:  1991-04-13

Review 3.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Interactions between conidia of Aspergillus fumigatus and human complement component C3.

Authors:  J E Sturtevant; J P Latgé
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Invasive aspergillosis in two patients with acute lymphoblastic leukaemia in complete remission.

Authors:  M L Turner; L Russell; L J Milne; A C Parker
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

6.  Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates.

Authors:  B Philippe; O Ibrahim-Granet; M C Prévost; M A Gougerot-Pocidalo; M Sanchez Perez; A Van der Meeren; J P Latgé
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level.

Authors:  B Jahn; A Rampp; C Dick; A Jahn; M Palmer; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.